We are live on ! Find out more
BC

Blackhill Capital Portfolio holdings

AUM $1.94B
1-Year Est. Return 18.09%
This Fund
S&P 500
This Quarter Est. Return
+1.22%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$828M
AUM Growth
+$7.95M
Cap. Flow
+$710K
Cap. Flow %
0.09%
Top 10 Hldgs %
76.34%
Holding
92
New
1
Increased
8
Reduced
9
Closed
1

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.27M
2
BAX icon
Baxter International
BAX
+$1.38M
3
KMI.WS
Kinder Morgan Inc
KMI.WS
+$819K
4
BMY icon
Bristol-Myers Squibb
BMY
+$527K
5
WSM icon
Williams-Sonoma
WSM
+$482K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3.12M
2
PG icon
Procter & Gamble
PG
+$1.61M
3
CIM
Chimera Investment
CIM
+$157K
4
KMI icon
Kinder Morgan
KMI
+$150K
5
GE icon
GE Aerospace
GE
+$135K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 49.97%
2 Healthcare 21.92%
3 Energy 12.66%
4 Consumer Staples 5.07%
5 Communication Services 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WSM icon
1
Williams-Sonoma
WSM
$29.5B
$407M 49.17%
9,897,266
+12,330
+0.1% +$482K
KMI icon
2
Kinder Morgan
KMI
$70.1B
$53.4M 6.45%
1,390,172
-3,585
-0.3% -$150K
BMY icon
3
Bristol-Myers Squibb
BMY
$130B
$30.8M 3.72%
463,152
+8,000
+2% +$527K
DIS icon
4
Walt Disney
DIS
$179B
$28.6M 3.45%
250,500
+3,900
+2% +$428K
PFE icon
5
Pfizer
PFE
$152B
$22.6M 2.73%
710,739
+69,564
+11% +$2.27M
JNJ icon
6
Johnson & Johnson
JNJ
$626B
$20.2M 2.44%
207,400
– –
ZTS icon
7
Zoetis
ZTS
$31.1B
$19.8M 2.4%
411,420
– –
ABBV icon
8
AbbVie
ABBV
$442B
$17.2M 2.07%
255,560
– –
ESRX
9
DELISTED
Express Scripts Holding Company
ESRX
$16.7M 2.01%
187,286
– –
SIAL
10
DELISTED
SIGMA - ALDRICH CORP
SIAL
$15.7M 1.9%
112,700
– –
MJN
11
DELISTED
Mead Johnson Nutrition Company
MJN
$15.5M 1.87%
171,728
– –
ZBH icon
12
Zimmer Biomet
ZBH
$18.5B
$13.1M 1.58%
123,238
-2
-0% -$221
LLY icon
13
Eli Lilly
LLY
$1.08T
$13.1M 1.58%
156,400
-41,000
-21% -$3.12M
ABT icon
14
Abbott
ABT
$190B
$12.7M 1.54%
259,560
– –
KMB icon
15
Kimberly-Clark
KMB
$36.1B
$11.2M 1.35%
105,700
– –
TCP
16
DELISTED
TC Pipelines LP
TCP
$9.84M 1.19%
172,650
– –
BAX icon
17
Baxter International
BAX
$14.3B
$9.8M 1.18%
258,108
+36,820
+17% +$1.38M
PM icon
18
Philip Morris
PM
$290B
$9.22M 1.11%
115,024
– –
GE icon
19
GE Aerospace
GE
$382B
$8.91M 1.08%
70,015
-1,043
-1% -$135K
AAPL icon
20
Apple
AAPL
$4.45T
$8.31M 1%
264,888
– –
EPD icon
21
Enterprise Products Partners
EPD
$81.8B
$7.03M 0.85%
235,218
– –
MMP
22
DELISTED
Magellan Midstream Partners, L.P.
MMP
$6.37M 0.77%
86,800
– –
EEQ
23
DELISTED
Enbridge Energy Management Llc
EEQ
$5.69M 0.69%
241,551
-20
-0% -$511
TPR icon
24
Tapestry
TPR
$32.4B
$5.54M 0.67%
160,000
– –
PG icon
25
Procter & Gamble
PG
$338B
$5.11M 0.62%
65,319
-20,000
-23% -$1.61M
1
2 3 4

Similar funds

FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
HC
Hamilton Capital Columbus, Ohio $1.93B AUM
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Blackhill Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Blackhill Capital held 92 positions worth $828M, up 0.97% from $820M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 2.2%. Blackhill Capital opened 1 new position and exited 1, leaving the 92-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 49% a quarter earlier, followed by Healthcare and Energy.

  • Blackhill Capital's largest Q2 2015 buy was Kinder Morgan Inc: 200,000 shares worth $540K.
  • Blackhill Capital added most to Pfizer in Q2 2015, an estimated $2.27M increase.
  • Blackhill Capital's biggest Q2 2015 reduction was Eli Lilly, cutting an estimated $3.12M.
  • Blackhill Capital fully exited Chimera Investment in Q2 2015, selling an estimated $157K.
  • Blackhill Capital's ten largest holdings make up 76% of its $828M portfolio in Q2 2015.
  • Blackhill Capital opened 1 new position and closed 1 in Q2 2015.
  • Blackhill Capital's portfolio value rose 0.97% quarter-over-quarter to $828M.

Based on Blackhill Capital's 13F filing for Q2 2015, filed 6 Aug 2015.